NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a software company that develops AI-powered pathology solutions, has announced the latest advancement in their automated quality control (QC) algorithm.

The collection of tissue material is an important component of many clinical trials studying the efficiency of different cancer therapies. It is hoped that molecular analyses of tissues of patients ...